IE
ANGO icon

Israel Englander’s AngioDynamics ANGO Stock Holding History

Israel Englander’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-30,000
Closed -$778K – 6732
2021
Q3 		$778K Buy
+30,000
New +$802K ﹤0.01% 4927

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Israel Englander's ANGO Position: Q2 2026 in Review

Israel Englander increased its AngioDynamics (ANGO) stake by 21% in Q2 2026, buying an estimated $1.58M and bringing the position to 783,125 shares worth $10.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2260.

Israel Englander first reported a position in ANGO in Q3 2013 and has held it in 46 quarters since. The position peaked at $43.6M in Q2 2021. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Israel Englander held 783,125 shares of AngioDynamics worth $10.2M as of Q2 2026.
  • Israel Englander bought 138,448 AngioDynamics shares in Q2 2026, an estimated $1.58M.
  • AngioDynamics made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2260 holding.
  • Israel Englander first reported a position in AngioDynamics in Q3 2013 and has held it in 46 quarters since.
  • Israel Englander's AngioDynamics position peaked at $43.6M in Q2 2021.
  • 161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.